The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
Archive — April 2024
Page 5 of 5 of this archive, newest first.
A shortage listing ends. 24 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
SURPASS-2 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Independent analysis puts a SWB dulaglutide lot at 96.2%, against 95.6% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Asparagine, glycine, and the two residues that decide a shelf life
An isoaspartate rearrangement changes the molecule and not the mass. A method that confirms identity by molecular weight alone will report it as the parent compound.
Grams per kilogram of what? The denominator problem in protein guidance
The practical difficulty is not knowing the target. It is meeting it on an appetite that has been pharmacologically reduced by half.
From the floor in Xianning: 17 posters, one theme
Reported from the sessions, and from the two hours afterwards.
What the new the United Kingdom guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What a 29% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.